Polymerized type I collagen down-regulates STAT-1 phosphorylation through engagement to LAIR-1 in M1-macrophages avoiding long COVID
Authors:
- Elizabeth Olivares-MartínezEOElizabeth Olivares-Martínez
- Diego Francisco Hernández-RamírezDHDiego Francisco Hernández-Ramírez
- Carlos Alberto Núñez-ÁlvarezCNCarlos Alberto Núñez-Álvarez
- Mónica Chapa-IbarguengoitiaMCMónica Chapa-Ibarguengoitia
- Silvia Méndez-FloresSMSilvia Méndez-Flores
- Ángel Priego- RaneroÁRÁngel Priego- Ranero
- Daniel Azamar-LlamasDADaniel Azamar-Llamas
- Héctor Olvera-PradoHOHéctor Olvera-Prado
- Kenia Ilian Rivas-RedondaKRKenia Ilian Rivas-Redonda
- Eric Ochoa-HeinEOEric Ochoa-Hein
- Luis Gerardo López-MosquedaLLLuis Gerardo López-Mosqueda
- Estefano Rojas-CastañedaEREstefano Rojas-Castañeda
Preprint
Abstract
Background: The polymerized type I collagen (PTIC) is a γ-irradiated mixture of pepsinized porcine type I collagen and polyvinylpyrrolidone (PVP). It has immunomodulatory properties. However, the receptor and signaling pathway through which it exerts its therapeutic effects has not yet been identified. Aim: To evaluate LAIR-1 as a potential receptor for PTIC and the signaling pathway evoked by ligand-receptor binding. Methods: LAIR-1 binding assay was performed by incubating various concentrations of recombinant human LAIR-1 with native type I collagen or PTIC. Macrophages M1- derived from THP-1 cells were cultured with 2-10% PTIC for 24 h. Cell lysates from THP- 1, monocytes-like cells (MLCs), M1, M1+IFN-γ, M1+LPS, and 2 or 10% PTIC treated M1 were analyzed by western blot for the transcription factors NF-κB (p65), p38, STAT-1, and pSTAT-1. Cytokines, Th1 cells, and M1/M2 macrophages were analyzed by luminometry and flow cytometry from blood samples of symptomatic COVID-19 outpatients on treatment with intramuscular administration of PTIC. Results: PTIC binds LAIR-1 with a similar affinity to native collagen. This binding decreases STAT-1 signaling IFN-γ-induced and IL-1β expression in M1 macrophages by down-regulating STAT-1 phosphorylation. Moreover, intramuscular PTIC treatment of symptomatic COVID-19 outpatients decreased at statistically significant levels the percentage of M1 macrophages and cytokines (IP-10, MIF, eotaxin, IL-8, IL-1RA, and M- CSF) associated with STAT-1 transcription factor and increased M2 macrophages and Th1 cells. The downregulation of inflammatory mediators was related to better oxygen saturation and decreased dyspnea, chest pain, cough, and chronic fatigue syndrome in the acute phase of infection and the long term. Conclusion: PTIC is an agonist of LAIR-1 and down-regulates STAT-1 phosphorylation. PTIC could be relevant for treating STAT-1-mediated inflammatory diseases, including COVID-19 and long COVIDKeywords
All Related Versions
This publication has 42 references indexed in Scilit:
- Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized sclerodermaClinical and Experimental Dermatology, 2012
- Polymerized-Type I Collagen Downregulates Inflammation and Improves Clinical Outcomes in Patients with Symptomatic Knee Osteoarthritis Following Arthroscopic Lavage: A Randomized, Double-Blind, and Placebo-Controlled Clinical TrialThe Scientific World Journal, 2012
- Polymerized-Type I Collagen Induces Upregulation of Foxp3-Expressing CD4 Regulatory T Cells and Downregulation of IL-17-Producing CD4T Cells (Th17) Cells in Collagen-Induced ArthritisJournal of Immunology Research, 2011
- Recent Advances in Underlying Pathologies Provide Insight into Interleukin-8 Expression-Mediated Inflammation and AngiogenesisInternational Journal of Inflammation, 2011
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genesProceedings of the National Academy of Sciences, 2009
- The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary diseaseEuropean Journal of Internal Medicine, 2008
- The inhibitory collagen receptor LAIR-1 (CD305)Journal of Leukocyte Biology, 2007
- Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1beta, TNF-alpha, TGF-beta1, ELAM-1 and VCAM-1 expression in scleroderma skin lesionsClinical and Experimental Dermatology, 2005
- Cellular and humoral responses to collagen–polyvinylpyrrolidone administered during short and long periods in humansCanadian Journal of Physiology and Pharmacology, 2003